Financial Metrics

BIO-B BIO-RAD LABORATORIES, INC.

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.42	—	USD/shares	10-Q	2017-05-09
Quarterly	2016-06-30	0.61	+45.2%	USD/shares	10-Q	2017-08-07
Quarterly	2016-09-30	0.62	+1.6%	USD/shares	10-Q	2017-11-09
Quarterly	2017-03-31	0.41	-33.9%	USD/shares	10-Q	2018-05-10
Quarterly	2017-06-30	0.17	-58.5%	USD/shares	10-Q	2018-08-09
Quarterly	2017-09-30	0.73	+329.4%	USD/shares	10-Q	2018-11-05
Quarterly	2018-03-31	21.77	+2882.2%	USD/shares	10-Q	2019-05-10
Quarterly	2018-06-30	8.87	-59.3%	USD/shares	10-Q	2019-08-06
Quarterly	2018-09-30	8.89	+0.2%	USD/shares	10-Q	2019-11-01
Quarterly	2019-03-31	28.74	+223.3%	USD/shares	10-Q	2020-05-08
Quarterly	2019-06-30	19.86	-30.9%	USD/shares	10-Q	2020-07-31
Quarterly	2019-09-30	-8.68	-143.7%	USD/shares	10-Q	2020-10-30
Quarterly	2020-03-31	22.72	+361.8%	USD/shares	10-Q	2021-04-30
Quarterly	2020-06-30	32.15	+41.5%	USD/shares	10-Q	2021-07-30
Quarterly	2020-09-30	43.64	+35.7%	USD/shares	10-Q	2021-10-29
Quarterly	2021-03-31	32.38	-25.8%	USD/shares	10-Q	2022-04-29
Quarterly	2021-06-30	30.32	-6.4%	USD/shares	10-Q	2022-07-29
Quarterly	2021-09-30	129.96	+328.6%	USD/shares	10-Q	2022-10-28
Quarterly	2022-03-31	-112.5	-186.6%	USD/shares	10-Q	2023-05-05
Quarterly	2022-06-30	-31.12	+72.3%	USD/shares	10-Q	2022-07-29
Quarterly	2022-09-30	-5.48	+82.4%	USD/shares	10-Q	2023-10-27
Quarterly	2023-03-31	2.32	+142.3%	USD/shares	10-Q	2024-05-08
Quarterly	2023-06-30	-39.59	-1806.5%	USD/shares	10-Q	2024-08-02
Quarterly	2023-09-30	3.64	+109.2%	USD/shares	10-Q	2024-10-31
Quarterly	2024-03-31	13.45	+269.5%	USD/shares	10-Q	2025-05-01
Quarterly	2024-06-30	-76.26	-667.0%	USD/shares	10-Q	2025-07-31
Quarterly	2024-09-30	23.34	+130.6%	USD/shares	10-Q	2025-10-29
Quarterly	2025-03-31	2.29	-90.2%	USD/shares	10-Q	2025-05-01
Quarterly	2025-06-30	11.67	+409.6%	USD/shares	10-Q	2025-07-31
Quarterly	2025-09-30	-12.7	-208.8%	USD/shares	10-Q	2025-10-29
Annual	2016-12-31	0.88	—	USD/shares	10-K	2019-04-01
Annual	2017-12-31	4.07	+362.5%	USD/shares	10-K	2020-03-02
Annual	2018-12-31	12.1	+197.3%	USD/shares	10-K	2021-02-16
Annual	2019-12-31	58.27	+381.6%	USD/shares	10-K	2022-02-11
Annual	2020-12-31	126.47	+117.0%	USD/shares	10-K	2023-02-17
Annual	2021-12-31	140.83	+11.4%	USD/shares	10-K	2024-02-16
Annual	2022-12-31	27.78	-80.3%	USD/shares	10-K	2024-02-16
Annual	2023-12-31	-21.82	-178.5%	USD/shares	10-K	2026-02-13
Annual	2024-12-31	-65.36	-199.5%	USD/shares	10-K	2026-02-13
Annual	2025-12-31	27.85	+142.6%	USD/shares	10-K	2026-02-13

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2018-12-31	438937000.0	—	USD	10-Q	2019-11-01
Quarterly	2019-03-31	437606000.0	-0.3%	USD	10-Q	2019-05-10
Quarterly	2019-06-30	437680000.0	+0.0%	USD	10-Q	2019-08-06
Quarterly	2019-09-30	437808000.0	+0.0%	USD	10-Q	2019-11-01
Quarterly	2019-12-31	13579000.0	-96.9%	USD	10-Q	2020-10-30
Quarterly	2020-03-31	12205000.0	-10.1%	USD	10-Q	2020-05-08
Quarterly	2020-06-30	12233000.0	+0.2%	USD	10-Q	2020-07-31
Quarterly	2020-09-30	12241000.0	+0.1%	USD	10-Q	2020-10-30
Quarterly	2020-12-31	12258000.0	+0.1%	USD	10-Q	2021-10-29
Quarterly	2021-03-31	10901000.0	-11.1%	USD	10-Q	2021-04-30
Quarterly	2021-06-30	10779000.0	-1.1%	USD	10-Q	2021-07-30
Quarterly	2021-09-30	10645000.0	-1.2%	USD	10-Q	2021-10-29
Quarterly	2021-12-31	10514000.0	-1.2%	USD	10-Q	2022-10-28
Quarterly	2022-03-31	1196739000.0	+11282.3%	USD	10-Q	2022-04-29
Quarterly	2022-06-30	1196943000.0	+0.0%	USD	10-Q	2022-07-29
Quarterly	2022-09-30	1197272000.0	+0.0%	USD	10-Q	2022-10-28
Quarterly	2022-12-31	1197716000.0	+0.0%	USD	10-Q	2023-10-27
Quarterly	2023-03-31	1198005000.0	+0.0%	USD	10-Q	2023-05-05
Quarterly	2023-06-30	1198384000.0	+0.0%	USD	10-Q	2023-08-04
Quarterly	2023-09-30	1198713000.0	+0.0%	USD	10-Q	2023-10-27
Quarterly	2023-12-31	1199052000.0	+0.0%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	1199381000.0	+0.0%	USD	10-Q	2024-05-08
Quarterly	2024-06-30	1199724000.0	+0.0%	USD	10-Q	2024-08-02
Quarterly	2024-09-30	1200062000.0	+0.0%	USD	10-Q	2024-10-31
Quarterly	2024-12-31	1200400000.0	+0.0%	USD	10-Q	2025-10-29
Quarterly	2025-03-31	1200700000.0	+0.0%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	1201100000.0	+0.0%	USD	10-Q	2025-07-31
Quarterly	2025-09-30	1202700000.0	+0.1%	USD	10-Q	2025-10-29
Annual	2022-12-31	1197700000.0	—	USD	10-K	2024-02-16
Annual	2023-12-31	1199100000.0	+0.1%	USD	10-K	2025-02-14
Annual	2024-12-31	1200400000.0	+0.1%	USD	10-K	2026-02-13
Annual	2025-12-31	1203000000.0	+0.2%	USD	10-K	2026-02-13

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	25296000.0	—	USD	10-Q	2017-05-09
Quarterly	2016-06-30	56865000.0	+124.8%	USD	10-Q	2017-08-07
Quarterly	2016-09-30	96323000.0	+69.4%	USD	10-Q	2017-11-09
Quarterly	2017-03-31	39332000.0	-59.2%	USD	10-Q	2018-05-10
Quarterly	2017-06-30	64951000.0	+65.1%	USD	10-Q	2018-08-09
Quarterly	2017-09-30	85264000.0	+31.3%	USD	10-Q	2018-11-05
Quarterly	2018-03-31	27184000.0	-68.1%	USD	10-Q	2019-05-10
Quarterly	2018-06-30	53897000.0	+98.3%	USD	10-Q	2019-08-06
Quarterly	2018-09-30	75951000.0	+40.9%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	23629000.0	-68.9%	USD	10-Q	2020-05-08
Quarterly	2019-06-30	45843000.0	+94.0%	USD	10-Q	2020-07-31
Quarterly	2019-09-30	76934000.0	+67.8%	USD	10-Q	2020-10-30
Quarterly	2020-03-31	21591000.0	-71.9%	USD	10-Q	2021-04-30
Quarterly	2020-06-30	39707000.0	+83.9%	USD	10-Q	2021-07-30
Quarterly	2020-09-30	59685000.0	+50.3%	USD	10-Q	2021-10-29
Quarterly	2021-03-31	19547000.0	-67.2%	USD	10-Q	2022-04-29
Quarterly	2021-06-30	42935000.0	+119.7%	USD	10-Q	2022-07-29
Quarterly	2021-09-30	77563000.0	+80.7%	USD	10-Q	2022-10-28
Quarterly	2022-03-31	33078000.0	-57.4%	USD	10-Q	2023-05-05
Quarterly	2022-06-30	50412000.0	+52.4%	USD	10-Q	2023-08-04
Quarterly	2022-09-30	77987000.0	+54.7%	USD	10-Q	2023-10-27
Quarterly	2023-03-31	35725000.0	-54.2%	USD	10-Q	2024-05-08
Quarterly	2023-06-30	70364000.0	+97.0%	USD	10-Q	2024-08-02
Quarterly	2023-09-30	114435000.0	+62.6%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	40200000.0	-64.9%	USD	10-Q	2025-05-01
Quarterly	2024-06-30	82500000.0	+105.2%	USD	10-Q	2025-07-31
Quarterly	2024-09-30	122700000.0	+48.7%	USD	10-Q	2025-10-29
Quarterly	2025-03-31	34400000.0	-72.0%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	80100000.0	+132.8%	USD	10-Q	2025-07-31
Quarterly	2025-09-30	111800000.0	+39.6%	USD	10-Q	2025-10-29
Annual	2016-12-31	141436000.0	—	USD	10-K	2019-04-01
Annual	2017-12-31	111332000.0	-21.3%	USD	10-K	2020-03-02
Annual	2018-12-31	129825000.0	+16.6%	USD	10-K	2021-02-16
Annual	2019-12-31	98532000.0	-24.1%	USD	10-K	2022-02-11
Annual	2020-12-31	108564000.0	+10.2%	USD	10-K	2023-02-17
Annual	2021-12-31	133746000.0	+23.2%	USD	10-K	2024-02-16
Annual	2022-12-31	112800000.0	-15.7%	USD	10-K	2025-02-14
Annual	2023-12-31	156700000.0	+38.9%	USD	10-K	2026-02-13
Annual	2024-12-31	165600000.0	+5.7%	USD	10-K	2026-02-13
Annual	2025-12-31	157600000.0	-4.8%	USD	10-K	2026-02-13

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	29506000.0	—	shares	10-Q	2017-05-09
Quarterly	2016-06-30	29589000.0	+0.3%	shares	10-Q	2017-08-07
Quarterly	2016-09-30	29671000.0	+0.3%	shares	10-Q	2017-11-09
Quarterly	2017-03-31	29911000.0	+0.8%	shares	10-Q	2018-05-10
Quarterly	2017-06-30	30006000.0	+0.3%	shares	10-Q	2018-08-09
Quarterly	2017-09-30	30052000.0	+0.2%	shares	10-Q	2018-11-05
Quarterly	2018-03-31	30171000.0	+0.4%	shares	10-Q	2019-05-10
Quarterly	2018-06-30	30219000.0	+0.2%	shares	10-Q	2019-08-06
Quarterly	2018-09-30	30292000.0	+0.2%	shares	10-Q	2019-11-01
Quarterly	2019-03-31	30104000.0	-0.6%	shares	10-Q	2020-05-08
Quarterly	2019-06-30	30154000.0	+0.2%	shares	10-Q	2020-07-31
Quarterly	2019-09-30	29831000.0	-1.1%	shares	10-Q	2020-10-30
Quarterly	2020-03-31	30196000.0	+1.2%	shares	10-Q	2021-04-30
Quarterly	2020-06-30	30058000.0	-0.5%	shares	10-Q	2021-07-30
Quarterly	2020-09-30	30128000.0	+0.2%	shares	10-Q	2021-10-29
Quarterly	2021-03-31	30186000.0	+0.2%	shares	10-Q	2022-04-29
Quarterly	2021-06-30	30148000.0	-0.1%	shares	10-Q	2022-07-29
Quarterly	2021-09-30	30224000.0	+0.3%	shares	10-Q	2022-10-28
Quarterly	2022-03-31	29933000.0	-1.0%	shares	10-Q	2023-05-05
Quarterly	2022-06-30	29794000.0	-0.5%	shares	10-Q	2023-08-04
Quarterly	2022-09-30	29733000.0	-0.2%	shares	10-Q	2023-10-27
Quarterly	2023-03-31	29747000.0	+0.0%	shares	10-Q	2024-05-08
Quarterly	2023-06-30	29355000.0	-1.3%	shares	10-Q	2024-08-02
Quarterly	2023-09-30	29223000.0	-0.4%	shares	10-Q	2024-10-31
Quarterly	2024-03-31	28537000.0	-2.3%	shares	10-Q	2025-05-01
Quarterly	2024-06-30	28395000.0	-0.5%	shares	10-Q	2025-07-31
Quarterly	2024-09-30	27985000.0	-1.4%	shares	10-Q	2025-10-29
Quarterly	2025-03-31	27955000.0	-0.1%	shares	10-Q	2025-05-01
Quarterly	2025-06-30	27228000.0	-2.6%	shares	10-Q	2025-07-31
Quarterly	2025-09-30	26923000.0	-1.1%	shares	10-Q	2025-10-29
Annual	2016-12-31	29646000.0	—	shares	10-K	2019-04-01
Annual	2017-12-31	30034000.0	+1.3%	shares	10-K	2020-03-02
Annual	2018-12-31	30228000.0	+0.6%	shares	10-K	2021-02-16
Annual	2019-12-31	30184000.0	-0.1%	shares	10-K	2022-02-11
Annual	2020-12-31	30160000.0	-0.1%	shares	10-K	2023-02-17
Annual	2021-12-31	30208000.0	+0.2%	shares	10-K	2024-02-16
Annual	2022-12-31	29785000.0	-1.4%	shares	10-K	2025-02-14
Annual	2023-12-31	29209000.0	-1.9%	shares	10-K	2026-02-13
Annual	2024-12-31	28214000.0	-3.4%	shares	10-K	2026-02-13
Annual	2025-12-31	27281000.0	-3.3%	shares	10-K	2026-02-13

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

1,203,000,000

Total Liabilities (latest annual)

3,122,900,000

Current Liabilities (latest annual)

517,000,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0048	—	ratio	10-Q	2017-05-09
Quarterly	2016-06-30	0.0116	+140.1%	ratio	10-Q	2017-08-07
Quarterly	2016-09-30	0.0180	+55.5%	ratio	10-Q	2017-11-09
Quarterly	2017-03-31	0.0046	-74.6%	ratio	10-Q	2018-05-10
Quarterly	2017-06-30	0.0018	-60.9%	ratio	10-Q	2018-08-09
Quarterly	2017-09-30	0.0077	+332.5%	ratio	10-Q	2018-11-05
Quarterly	2018-03-31	0.1463	+1788.9%	ratio	10-Q	2019-11-01
Quarterly	2018-06-30	0.0578	-60.5%	ratio	10-Q	2019-11-01
Quarterly	2018-09-30	0.0550	-4.9%	ratio	10-Q	2019-11-01
Quarterly	2019-03-31	0.1779	+223.7%	ratio	10-Q	2020-10-30
Quarterly	2019-06-30	0.1091	-38.6%	ratio	10-Q	2020-10-30
Quarterly	2019-09-30	-0.0504	-146.2%	ratio	10-Q	2020-10-30
Quarterly	2020-03-31	0.1090	+316.1%	ratio	10-Q	2021-10-29
Quarterly	2020-06-30	0.1314	+20.6%	ratio	10-Q	2021-10-29
Quarterly	2020-09-30	0.1490	+13.4%	ratio	10-Q	2021-10-29
Quarterly	2021-03-31	0.0921	-38.2%	ratio	10-Q	2022-10-28
Quarterly	2021-06-30	0.0788	-14.4%	ratio	10-Q	2022-10-28
Quarterly	2021-09-30	0.2562	+225.0%	ratio	10-Q	2022-10-28
Quarterly	2022-03-31	-0.3300	-228.8%	ratio	10-Q	2023-10-27
Quarterly	2022-06-30	-0.1034	+68.7%	ratio	10-Q	2023-10-27
Quarterly	2022-09-30	-0.0192	+81.4%	ratio	10-Q	2023-10-27
Quarterly	2023-03-31	0.0071	+136.8%	ratio	10-Q	2024-10-31
Quarterly	2023-06-30	-0.1376	-2048.1%	ratio	10-Q	2024-10-31
Quarterly	2023-09-30	0.0126	+109.2%	ratio	10-Q	2024-10-31
Quarterly	2024-03-31	0.0424	+235.9%	ratio	10-Q	2025-10-29
Quarterly	2024-06-30	-0.3194	-853.2%	ratio	10-Q	2025-10-29
Quarterly	2024-09-30	0.0872	+127.3%	ratio	10-Q	2025-10-29
Quarterly	2025-03-31	0.0096	-89.0%	ratio	10-Q	2025-10-29
Quarterly	2025-06-30	0.0446	+365.3%	ratio	10-Q	2025-10-29
Quarterly	2025-09-30	-0.0508	-213.8%	ratio	10-Q	2025-10-29
Annual	2016-12-31	0.0101	—	ratio	10-K	2019-04-01
Annual	2017-12-31	0.0417	+313.9%	ratio	10-K	2020-03-02
Annual	2018-12-31	0.0909	+118.0%	ratio	10-K	2021-02-16
Annual	2019-12-31	0.3055	+235.9%	ratio	10-K	2022-02-11
Annual	2020-12-31	0.3857	+26.2%	ratio	10-K	2023-02-17
Annual	2021-12-31	0.3109	-19.4%	ratio	10-K	2024-02-16
Annual	2022-12-31	-0.3773	-221.4%	ratio	10-K	2025-02-14
Annual	2023-12-31	-0.0729	+80.7%	ratio	10-K	2026-02-13
Annual	2024-12-31	-0.2807	-285.0%	ratio	10-K	2026-02-13
Annual	2025-12-31	0.1020	+136.3%	ratio	10-K	2026-02-13

8-K Material Event Details

53 filings · 103 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

494 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2025-11-06	BARRY JAMES	EVP, President, LSG	Open-market sell S	Bio-Rad A Common Stock	700	$306.18	$214,289	510
2025-10-24	DiVincenzo Jonathan P.	President & COO	Exercise / conversion M · derivative	Restricted Stock Units	1,869	$0.00	$0	5,609
2025-10-24	DiVincenzo Jonathan P.	President & COO	Other disposed transaction F	Bio-Rad A Common Stock	950	$339.75	$322,762	919
2025-10-24	DiVincenzo Jonathan P.	President & COO	Exercise / conversion M	Bio-Rad A Common Stock	1,869	$0.00	$0	1,869
2025-10-20	EVRAN SEDAT	EVP, Global Supply Chain	Exercise / conversion M · derivative	Restricted Stock Units	1,044	$0.00	$0	2,088
2025-10-20	EVRAN SEDAT	EVP, Global Supply Chain	Other disposed transaction F	Bio-Rad A Common Stock	335	$321.90	$107,836	2,233
2025-10-20	EVRAN SEDAT	EVP, Global Supply Chain	Exercise / conversion M	Bio-Rad A Common Stock	1,044	$0.00	$0	2,568
2025-09-06	EVRAN SEDAT	EVP, Global Supply Chain	Exercise / conversion M · derivative	Restricted Stock Units	864	$0.00	$0	2,592
2025-09-06	EVRAN SEDAT	EVP, Global Supply Chain	Other disposed transaction F	Bio-Rad A Common Stock	277	$295.43	$81,834	1,524
2025-09-06	EVRAN SEDAT	EVP, Global Supply Chain	Exercise / conversion M	Bio-Rad A Common Stock	864	$0.00	$0	1,801
2025-09-05	EVRAN SEDAT	EVP, Global Supply Chain	Equity grant / award A · derivative	Restricted Stock Units	4,110	$0.00	$0	4,110
2025-09-01	Allison Schwartz	Dir	Exercise / conversion M · derivative	Restricted Stock Units	74	$0.00	$0	150
2025-09-01	Allison Schwartz	Dir	Exercise / conversion M · derivative	Restricted Stock Units	42	$0.00	$0	42
2025-09-01	Allison Schwartz	Dir	Exercise / conversion M · derivative	Restricted Stock Units	31	$0.00	$0	0
2025-09-01	Allison Schwartz	Dir	Other disposed transaction F	Bio-Rad A Common Stock	55	$297.88	$16,383	1,397
2025-09-01	Allison Schwartz	Dir	Exercise / conversion M	Bio-Rad A Common Stock	147	$0.00	$0	1,452
2025-07-25	ENGELHARDT EVA ANETTE	EVP, President, CDG	Exercise / conversion M · derivative	Restricted Stock Units	245	$0.00	$0	738
2025-07-25	ENGELHARDT EVA ANETTE	EVP, President, CDG	Other disposed transaction F	Bio-Rad A Common Stock	88	$264.19	$23,249	157
2025-07-25	ENGELHARDT EVA ANETTE	EVP, President, CDG	Exercise / conversion M	Bio-Rad A Common Stock	245	$0.00	$0	245
2025-04-24	Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Units	1,077	$0.00	$0	3,234
2025-04-24	Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Other disposed transaction F	Bio-Rad A Common Stock	386	$249.74	$96,400	845
2025-04-24	Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Exercise / conversion M	Bio-Rad A Common Stock	1,077	$0.00	$0	1,231
2025-04-22	PINKSTON ARNOLD A	Dir	Exercise / conversion M · derivative	Restricted Stock Units	308	$0.00	$0	0
2025-04-22	PINKSTON ARNOLD A	Dir	Equity grant / award A · derivative	Restricted Stock Units	407	$0.00	$0	407
2025-04-22	PINKSTON ARNOLD A	Dir	Exercise / conversion M	Bio-Rad A Common Stock	308	$0.00	$0	308
2025-03-14	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,000	$0.00	$0	0
2025-03-14	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	3,000	$247.06	$741,184	8,171
2025-03-14	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M	Bio-Rad A Common Stock	3,000	$159.32	$477,960	11,171
2025-03-03	SCHWARTZ NORMAN D	Chairman & CEO	Equity grant / award A · derivative	Non-Qualified Stock Option (right to buy)	11,671	$0.00	$0	11,671
2024-10-24	DiVincenzo Jonathan P.	President & COO	Equity grant / award A · derivative	Restricted Stock Units	7,478	$0.00	$0	7,478
2024-10-20	EVRAN SEDAT	EVP, Global Supply Chain	Exercise / conversion M · derivative	Restricted Stock Units	1,044	$0.00	$0	3,132
2024-10-20	EVRAN SEDAT	EVP, Global Supply Chain	Other disposed transaction F	Bio-Rad A Common Stock	335	$346.37	$116,034	853
2024-10-20	EVRAN SEDAT	EVP, Global Supply Chain	Exercise / conversion M	Bio-Rad A Common Stock	1,044	$0.00	$0	1,188
2024-09-06	ENGELHARDT EVA ANETTE	EVP, President, CDG	Equity grant / award A · derivative	Restricted Stock Units	4,608	$0.00	$0	4,608
2024-09-03	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M · derivative	Restricted Stock Units	557	$0.00	$0	0
2024-09-03	Crowley Michael	EVP, GBL Commercial Operations	Other disposed transaction F	Bio-Rad A Common Stock	283	$334.31	$94,610	8,171
2024-09-03	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M	Bio-Rad A Common Stock	557	$0.00	$0	8,454
2024-09-02	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M · derivative	Restricted Stock Units	434	$0.00	$0	0
2024-09-02	Crowley Michael	EVP, GBL Commercial Operations	Other disposed transaction F	Bio-Rad A Common Stock	155	$337.32	$52,285	7,897
2024-09-02	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M	Bio-Rad A Common Stock	434	$0.00	$0	8,052
2024-09-01	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M · derivative	Restricted Stock Units	405	$0.00	$0	406
2024-09-01	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M · derivative	Restricted Stock Units	520	$0.00	$0	1,042
2024-09-01	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M · derivative	Restricted Stock Units	751	$0.00	$0	2,254
2024-09-01	Crowley Michael	EVP, GBL Commercial Operations	Other disposed transaction F	Bio-Rad A Common Stock	145	$337.32	$48,911	7,618
2024-09-01	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M	Bio-Rad A Common Stock	405	$0.00	$0	7,763
2024-09-01	Crowley Michael	EVP, GBL Commercial Operations	Other disposed transaction F	Bio-Rad A Common Stock	218	$337.32	$73,536	7,358
2024-09-01	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M	Bio-Rad A Common Stock	520	$0.00	$0	7,576
2024-09-01	Crowley Michael	EVP, GBL Commercial Operations	Other disposed transaction F	Bio-Rad A Common Stock	268	$337.32	$90,402	7,056
2024-09-01	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M	Bio-Rad A Common Stock	751	$0.00	$0	7,324
2024-08-26	Allison Schwartz	Dir	Equity grant / award G	Bio-Rad B Common Stock	57	$0.00	$0	3,996
2024-07-25	ENGELHARDT EVA ANETTE	EVP, President, CDG	Equity grant / award A · derivative	Restricted Stock Units	983	$0.00	$0	983
2024-06-13	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	369	$281.91	$104,023	6,573
2024-04-29	Last Andrew J.	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Restricted Stock Units	1,000	$0.00	$0	0
2024-04-29	Last Andrew J.	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	357	$277.11	$98,928	5,720
2024-04-29	Last Andrew J.	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	1,000	$0.00	$0	6,077
2024-04-24	Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Equity grant / award A · derivative	Restricted Stock Units	4,311	$0.00	$0	4,311
2024-03-08	Last Andrew J.	EVP, Chief Operating Officer	Equity grant / award A · derivative	Non-Qualified Stock Option (right to buy)	5,891	$0.00	$0	5,891
2024-02-28	ERNST TIMOTHY S	EVP, General Counsel & Sec	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	2,500	$0.00	$0	0
2024-02-28	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	2,500	$330.55	$826,375	3,397
2024-02-28	ERNST TIMOTHY S	EVP, General Counsel & Sec	Exercise / conversion M	Bio-Rad A Common Stock	2,500	$326.15	$815,375	5,897
2024-02-27	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,000	$0.00	$0	0
2024-02-27	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	3,000	$336.00	$1,008,000	6,942
2024-02-27	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M	Bio-Rad A Common Stock	3,000	$215.98	$647,940	9,942
2023-12-16	WRIGHT DARA	EVP, President, CDG	Exercise / conversion M · derivative	Restricted Stock Units	502	$0.00	$0	503
2023-12-16	WRIGHT DARA	EVP, President, CDG	Other disposed transaction F	Bio-Rad A Common Stock	174	$306.12	$53,265	1,827
2023-12-16	WRIGHT DARA	EVP, President, CDG	Exercise / conversion M	Bio-Rad A Common Stock	502	$0.00	$0	2,001
2023-12-12	WRIGHT DARA	EVP, President, CDG	Open-market sell S	Bio-Rad A Common Stock	1,200	$299.16	$358,992	1,499
2023-12-05	SCHWARTZ STEVEN D	10%	Equity grant / award G	Bio-Rad B Common Stock	49	$0.00	$0	12,949
2023-11-28	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	642	$305.10	$195,874	6,942
2023-11-01	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	15,000	$0.00	$0	0
2023-11-01	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	16,000	$0.00	$0	0
2023-11-01	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	35,000	$0.00	$0	0
2023-11-01	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	12,024	$273.00	$3,282,552	361,360
2023-11-01	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	15,000	$159.32	$2,389,800	373,384
2023-11-01	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	12,274	$273.00	$3,350,802	358,384
2023-11-01	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	16,000	$139.56	$2,232,960	370,658
2023-11-01	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	25,642	$273.00	$7,000,266	354,658
2023-11-01	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	35,000	$119.80	$4,193,000	380,300
2023-10-20	EVRAN SEDAT	EVP, Global Supply Chain	Equity grant / award A · derivative	Restricted Stock Units	4,176	$0.00	$0	4,176
2023-09-02	Last Andrew J.	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Restricted Stock Units	903	$0.00	$0	903
2023-09-02	Last Andrew J.	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	448	$394.60	$176,781	5,040
2023-09-02	Last Andrew J.	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	903	$0.00	$0	5,488
2023-09-01	Last Andrew J.	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Restricted Stock Units	633	$0.00	$0	1,266
2023-09-01	Last Andrew J.	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Restricted Stock Units	867	$0.00	$0	2,602
2023-09-01	Last Andrew J.	EVP, Chief Operating Officer	Equity grant / award A · derivative	Restricted Stock Units	5,008	$0.00	$0	5,008
2023-09-01	Last Andrew J.	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	279	$394.60	$110,093	4,585
2023-09-01	Last Andrew J.	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	633	$0.00	$0	4,864
2023-09-01	Last Andrew J.	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	430	$394.60	$169,678	4,231
2023-09-01	Last Andrew J.	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	867	$0.00	$0	4,661
2023-08-30	ERNST TIMOTHY S	EVP, General Counsel & Sec	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	2,350	$0.00	$0	0
2023-08-30	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	377	$396.44	$149,458	2,416
2023-08-30	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	1,582	$395.76	$626,092	2,793
2023-08-30	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	391	$394.16	$154,117	4,375
2023-08-30	ERNST TIMOTHY S	EVP, General Counsel & Sec	Exercise / conversion M	Bio-Rad A Common Stock	2,350	$215.98	$507,553	4,766
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	39,000	$0.00	$0	0
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	2,600	$0.00	$0	0
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	2,320	$0.00	$0	2,320
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	1,805	$0.00	$0	1,805
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	1,266	$0.00	$0	2,532
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	2,081	$0.00	$0	6,245
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	25,389	$381.78	$9,693,012	345,300
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	39,000	$117.50	$4,582,500	370,689
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad A Common Stock	1,290	$381.78	$492,496	432,920
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad A Common Stock	2,600	$0.00	$0	434,210
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad A Common Stock	1,151	$381.78	$439,429	431,610
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad A Common Stock	2,320	$0.00	$0	432,761
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad A Common Stock	895	$381.78	$341,693	430,441
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad A Common Stock	1,805	$0.00	$0	431,336
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad A Common Stock	628	$381.78	$239,758	429,531
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad A Common Stock	1,266	$0.00	$0	430,159
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad A Common Stock	1,032	$381.78	$393,997	428,893
2023-08-25	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad A Common Stock	2,081	$0.00	$0	429,925
2023-08-23	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	300	$384.69	$115,407	2,416
2023-06-15	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	500	$379.39	$189,695	6,040
2023-06-06	RAMALINGAM AJIT	SVP, Chief Accounting Officer	Open-market sell S	Bio-Rad A Common Stock	181	$368.28	$66,659	0
2023-06-06	RAMALINGAM AJIT	SVP, Chief Accounting Officer	Open-market sell S	Bio-Rad A Common Stock	17	$368.49	$6,394	181
2023-05-03	SCHWARTZ STEVEN D	10%	Open-market sell S	Bio-Rad A Common Stock	320	$463.86	$148,435	1,498
2023-04-29	Last Andrew J.	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Restricted Stock Units	1,000	$0.00	$0	1,000
2023-04-29	Last Andrew J.	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	346	$450.79	$155,973	3,767
2023-04-29	Last Andrew J.	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	1,000	$0.00	$0	4,113
2023-04-08	Daskal Ilan	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Units	700	$0.00	$0	700
2023-04-08	Daskal Ilan	EVP, Chief Financial Officer	Other disposed transaction F	Bio-Rad A Common Stock	243	$466.24	$113,296	1,493
2023-04-08	Daskal Ilan	EVP, Chief Financial Officer	Exercise / conversion M	Bio-Rad A Common Stock	700	$0.00	$0	1,736
2023-03-08	ERNST TIMOTHY S	EVP, General Counsel & Sec	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	150	$0.00	$0	2,350
2023-03-08	ERNST TIMOTHY S	EVP, General Counsel & Sec	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	850	$0.00	$0	0
2023-03-08	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	746	$486.89	$363,220	2,671
2023-03-08	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	1,000	$486.08	$486,080	3,417
2023-03-08	ERNST TIMOTHY S	EVP, General Counsel & Sec	Exercise / conversion M	Bio-Rad A Common Stock	150	$215.98	$32,397	4,417
2023-03-08	ERNST TIMOTHY S	EVP, General Counsel & Sec	Exercise / conversion M	Bio-Rad A Common Stock	850	$159.32	$135,422	4,267
2023-02-10	RAMALINGAM AJIT	SVP, Chief Accounting Officer	Equity grant / award A · derivative	Restricted Stock Units	644	$0.00	$0	644
2022-12-16	WRIGHT DARA	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	502	$0.00	$0	1,005
2022-12-16	WRIGHT DARA	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	226	$407.98	$92,203	1,762
2022-12-16	WRIGHT DARA	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	502	$0.00	$0	1,988
2022-11-10	RAMALINGAM AJIT	SVP, Chief Accounting Officer	Open-market sell S	Bio-Rad A Common Stock	0	$423.61	$161	0
2022-11-10	RAMALINGAM AJIT	SVP, Chief Accounting Officer	Open-market sell S	Bio-Rad A Common Stock	112	$422.28	$47,295	0
2022-11-10	RAMALINGAM AJIT	SVP, Chief Accounting Officer	Open-market sell S	Bio-Rad A Common Stock	267	$421.70	$112,594	112
2022-11-07	SCHWARTZ STEVEN D	10%	Equity grant / award G	Bio-Rad B Common Stock	42	$0.00	$0	12,900
2022-09-02	WRIGHT DARA	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	433	$0.00	$0	867
2022-09-02	WRIGHT DARA	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	150	$478.32	$71,748	1,460
2022-09-02	WRIGHT DARA	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	433	$0.00	$0	1,610
2022-09-01	WRIGHT DARA	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	405	$0.00	$0	1,216
2022-09-01	WRIGHT DARA	Executive Vice President	Equity grant / award A · derivative	Restricted Stock Units	2,082	$0.00	$0	2,082
2022-09-01	WRIGHT DARA	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	141	$486.25	$68,561	1,177
2022-09-01	WRIGHT DARA	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	405	$0.00	$0	1,318
2022-08-26	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	39,250	$0.00	$0	0
2022-08-26	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	23,749	$495.28	$11,762,405	331,647
2022-08-26	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	39,250	$107.32	$4,212,310	355,396
2022-08-05	RAMALINGAM AJIT	SVP, Chief Accounting Officer	Open-market sell S	Bio-Rad A Common Stock	518	$537.00	$278,166	98
2022-04-29	Last Andrew J.	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Restricted Stock Units	1,000	$0.00	$0	2,000
2022-04-29	Last Andrew J.	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	471	$512.06	$241,180	2,293
2022-04-29	Last Andrew J.	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	1,000	$0.00	$0	2,764
2022-04-08	Daskal Ilan	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Units	700	$0.00	$0	1,400
2022-04-08	Daskal Ilan	EVP, Chief Financial Officer	Other disposed transaction F	Bio-Rad A Common Stock	257	$597.16	$153,470	452
2022-04-08	Daskal Ilan	EVP, Chief Financial Officer	Exercise / conversion M	Bio-Rad A Common Stock	700	$0.00	$0	709
2021-12-16	WRIGHT DARA	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	502	$0.00	$0	1,507
2021-12-16	WRIGHT DARA	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	221	$734.34	$162,289	892
2021-12-16	WRIGHT DARA	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	502	$0.00	$0	1,113
2021-11-12	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	600	$0.00	$0	0
2021-11-12	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	2,400	$0.00	$0	600
2021-11-12	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,800	$0.00	$0	1,200
2021-11-12	TUMOLO ANNETTE	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	4,800	$750.05	$3,600,240	4,593
2021-11-12	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	1,800	$326.15	$587,070	9,393
2021-11-12	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	2,400	$215.98	$518,352	7,593
2021-11-12	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	600	$159.32	$95,592	5,193
2021-11-11	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,113	$0.00	$0	1,671
2021-11-11	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	433	$0.00	$0	1,300
2021-11-11	TUMOLO ANNETTE	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	500	$750.00	$375,000	4,593
2021-11-11	TUMOLO ANNETTE	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	613	$748.84	$459,039	5,093
2021-11-11	TUMOLO ANNETTE	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	433	$748.08	$323,919	5,706
2021-11-11	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	433	$524.30	$227,022	6,139
2021-11-11	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	500	$333.34	$166,670	5,706
2021-11-11	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	613	$333.34	$204,337	5,206
2021-11-09	SCHWARTZ NORMAN D	Chairman, President, and CEO	Equity grant / award G	Bio-Rad B Common Stock	20	$0.00	$0	12,858
2021-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	37,000	$0.00	$0	0
2021-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	3,000	$0.00	$0	0
2021-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	20,660	$806.32	$16,658,571	316,126
2021-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	37,000	$100.06	$3,702,220	336,786
2021-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	1,488	$806.32	$1,199,804	299,786
2021-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	3,000	$0.00	$0	301,274
2021-09-05	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	600
2021-09-05	Crowley Michael	EVP, GBL Commercial Operations	Other disposed transaction F	Bio-Rad A Common Stock	298	$819.70	$244,271	4,771
2021-09-05	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M	Bio-Rad A Common Stock	600	$0.00	$0	5,069
2021-09-04	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	1,200
2021-09-04	Crowley Michael	EVP, GBL Commercial Operations	Other disposed transaction F	Bio-Rad A Common Stock	298	$819.70	$244,271	4,469
2021-09-04	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M	Bio-Rad A Common Stock	600	$0.00	$0	4,767
2021-09-03	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M · derivative	Restricted Stock Units	557	$0.00	$0	1,671
2021-09-03	Crowley Michael	EVP, GBL Commercial Operations	Other disposed transaction F	Bio-Rad A Common Stock	277	$819.70	$227,057	4,167
2021-09-03	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M	Bio-Rad A Common Stock	557	$0.00	$0	4,444
2021-09-02	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	1,805	$0.00	$0	5,415
2021-09-02	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad A Common Stock	895	$825.77	$739,064	419,881
2021-09-02	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad A Common Stock	1,805	$0.00	$0	420,776
2021-09-02	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	433	$0.00	$0	1,300
2021-09-02	TUMOLO ANNETTE	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	150	$825.77	$123,866	3,382
2021-09-02	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	433	$0.00	$0	3,532
2021-09-01	SCHWARTZ NORMAN D	Chairman, President, and CEO	Equity grant / award A · derivative	Non-Qualified Stock Option (right to buy)	5,064	$0.00	$0	5,064
2021-09-01	SCHWARTZ NORMAN D	Chairman, President, and CEO	Equity grant / award A · derivative	Restricted Stock Units	5,064	$0.00	$0	5,064
2021-08-26	TUMOLO ANNETTE	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	600	$792.58	$475,548	3,099
2021-08-09	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,000	$0.00	$0	0
2021-08-09	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	430	$755.72	$324,960	3,669
2021-08-09	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	2,570	$754.80	$1,939,836	4,099
2021-08-09	Crowley Michael	EVP, GBL Commercial Operations	Exercise / conversion M	Bio-Rad A Common Stock	3,000	$139.56	$418,680	6,669
2021-08-04	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	327	$760.26	$248,605	919
2021-04-29	RAMALINGAM AJIT	SVP, Chief Accounting Officer	Exercise / conversion M · derivative	Restricted Stock Units	276	$0.00	$0	1,108
2021-04-29	RAMALINGAM AJIT	SVP, Chief Accounting Officer	Other disposed transaction F	Bio-Rad A Common Stock	96	$640.73	$61,510	222
2021-04-29	RAMALINGAM AJIT	SVP, Chief Accounting Officer	Exercise / conversion M	Bio-Rad A Common Stock	276	$0.00	$0	318
2021-04-08	Daskal Ilan	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Units	700	$0.00	$0	2,100
2021-04-08	Daskal Ilan	EVP, Chief Financial Officer	Other disposed transaction F	Bio-Rad A Common Stock	250	$592.23	$148,058	907
2021-04-08	Daskal Ilan	EVP, Chief Financial Officer	Exercise / conversion M	Bio-Rad A Common Stock	700	$0.00	$0	1,157
2021-02-19	ERNST TIMOTHY S	EVP, General Counsel & Sec	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	400	$0.00	$0	850
2021-02-19	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	196	$640.17	$125,542	1,220
2021-02-19	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	327	$640.92	$209,581	1,416
2021-02-19	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	400	$640.94	$256,376	1,743
2021-02-19	ERNST TIMOTHY S	EVP, General Counsel & Sec	Exercise / conversion M	Bio-Rad A Common Stock	400	$159.32	$63,728	2,143
2020-12-16	WRIGHT DARA	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	502	$0.00	$0	2,009
2020-12-16	WRIGHT DARA	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	174	$576.72	$100,349	328
2020-12-16	WRIGHT DARA	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	502	$0.00	$0	502
2020-12-15	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	374	$580.67	$217,171	3,669
2020-12-07	SCHWARTZ ALICE N	Dir	Equity grant / award G	Bio-Rad A Common Stock	1,800	$0.00	$0	1,791,821
2020-12-04	SCHWARTZ STEVEN D	10%	Equity grant / award G	Bio-Rad B Common Stock	27	$0.00	$0	12,838
2020-12-04	SCHWARTZ ALICE N	Dir	Equity grant / award G	Bio-Rad B Common Stock	162	$0.00	$0	438,518
2020-11-09	TUMOLO ANNETTE	Executive Vice President	Equity grant / award G	Bio-Rad A Common Stock	423	$0.00	$0	3,699
2020-11-06	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,200	$0.00	$0	600
2020-11-06	TUMOLO ANNETTE	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	246	$641.53	$157,816	4,122
2020-11-06	TUMOLO ANNETTE	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	734	$640.78	$470,333	4,368
2020-11-06	TUMOLO ANNETTE	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	220	$639.62	$140,716	5,102
2020-11-06	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	1,200	$159.32	$191,184	5,322
2020-09-11	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Restricted Stock Units	500	$0.00	$0	0
2020-09-11	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	500	$0.00	$0	0
2020-09-11	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	248	$505.02	$125,245	22,495
2020-09-11	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	318	$505.02	$160,596	22,243
2020-09-11	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	500	$0.00	$0	22,743
2020-09-11	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	3,200	$0.00	$0	0
2020-09-11	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	1,587	$505.02	$801,467	298,247
2020-09-11	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	3,200	$0.00	$0	299,834
2020-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	371	$0.00	$0	1,485
2020-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	500	$0.00	$0	1,500
2020-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	400	$0.00	$0	400
2020-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	308	$503.45	$155,063	22,061
2020-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	371	$333.34	$123,669	22,369
2020-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	412	$503.45	$207,421	21,998
2020-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	357	$503.45	$179,732	21,910
2020-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	500	$326.15	$163,075	22,410
2020-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	263	$503.45	$132,407	21,767
2020-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	400	$160.37	$64,148	22,030
2020-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Restricted Stock Units	400	$0.00	$0	400
2020-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	199	$478.82	$95,285	21,630
2020-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	400	$0.00	$0	21,829
2020-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	3,000	$0.00	$0	3,000
2020-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	1,488	$480.20	$714,538	296,634
2020-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	3,000	$0.00	$0	298,122
2020-09-05	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	2,600	$0.00	$0	5,200
2020-09-05	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad A Common Stock	1,290	$484.23	$624,657	418,971
2020-09-05	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad A Common Stock	2,600	$0.00	$0	420,261
2020-09-04	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	2,600	$0.00	$0	7,800
2020-09-04	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad A Common Stock	1,290	$484.23	$624,657	417,661
2020-09-04	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad A Common Stock	2,600	$0.00	$0	418,951
2020-09-03	SCHWARTZ NORMAN D	Chairman, President and CEO	Exercise / conversion M · derivative	Restricted Stock Units	2,319	$0.00	$0	9,278
2020-09-03	SCHWARTZ NORMAN D	Chairman, President and CEO	Other disposed transaction F	Bio-Rad A Common Stock	1,150	$494.24	$568,376	416,351
2020-09-03	SCHWARTZ NORMAN D	Chairman, President and CEO	Exercise / conversion M	Bio-Rad A Common Stock	2,319	$0.00	$0	417,501
2020-09-02	ERNST TIMOTHY S	EVP, General Counsel & Sec	Equity grant / award A · derivative	Non-Qualified Stock Option (right to buy)	1,444	$0.00	$0	1,444
2020-09-02	ERNST TIMOTHY S	EVP, General Counsel & Sec	Equity grant / award A · derivative	Restricted Stock Units	1,444	$0.00	$0	1,444
2020-09-02	RAMALINGAM AJIT	SVP, Chief Accounting Officer	Equity grant / award A · derivative	Restricted Stock Units	963	$0.00	$0	963
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	500	$0.00	$0	2,000
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,000	$0.00	$0	1,500
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,200	$0.00	$0	800
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	2,000	$0.00	$0	500
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,000	$0.00	$0	0
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,200	$0.00	$0	0
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,250	$0.00	$0	0
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,500	$0.00	$0	0
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Open-market sell S	Bio-Rad A Common Stock	339	$521.86	$176,911	20,738
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Open-market sell S	Bio-Rad A Common Stock	5,668	$520.94	$2,952,688	21,077
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Open-market sell S	Bio-Rad A Common Stock	1,133	$519.89	$589,035	26,745
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Open-market sell S	Bio-Rad A Common Stock	5,392	$518.76	$2,797,154	27,878
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Open-market sell S	Bio-Rad A Common Stock	315	$517.64	$163,057	33,270
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	500	$326.15	$163,075	33,585
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	1,000	$215.98	$215,980	33,085
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	1,200	$160.37	$192,444	32,085
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	2,000	$139.56	$279,120	30,885
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	3,000	$119.54	$358,620	28,885
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	3,200	$117.00	$374,400	25,885
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	3,250	$107.32	$348,790	22,685
2020-08-19	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	3,500	$98.04	$343,140	19,435
2020-08-18	Magni Giovanni	EVP, Chief Strategy Officer	Open-market sell S	Bio-Rad A Common Stock	2,382	$518.81	$1,235,805	12,435
2020-06-12	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	37,000	$0.00	$0	0
2020-06-12	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	21,860	$448.85	$9,811,861	295,122
2020-06-12	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	37,000	$84.57	$3,129,090	316,982
2020-06-01	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	1,500	$485.40	$728,100	2,310
2020-05-13	HUTTON RONALD W	Vice President and Treasurer	Open-market sell S	Bio-Rad A Common Stock	443	$457.35	$202,606	4,140
2020-04-29	RAMALINGAM AJIT	EVP, Chief Accounting Officer	Equity grant / award A · derivative	Restricted Stock Units	1,384	$0.00	$0	1,384
2020-04-08	Daskal Ilan	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Units	700	$0.00	$0	2,800
2020-04-08	Daskal Ilan	EVP, Chief Financial Officer	Other disposed transaction F	Bio-Rad A Common Stock	243	$403.06	$97,944	457
2020-04-08	Daskal Ilan	EVP, Chief Financial Officer	Exercise / conversion M	Bio-Rad A Common Stock	700	$0.00	$0	700
2019-12-16	WRIGHT DARA	Executive Vice President	Equity grant / award A · derivative	Non-Qualified Stock Option (right to buy)	2,511	$0.00	$0	2,511
2019-12-16	WRIGHT DARA	Executive Vice President	Equity grant / award A · derivative	Restricted Stock Units	2,511	$0.00	$0	2,511
2019-12-04	ERNST TIMOTHY S	EVP, General Counsel & Sec	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,250	$0.00	$0	1,250
2019-12-04	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	656	$370.12	$242,799	456
2019-12-04	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	1,250	$370.11	$462,638	1,112
2019-12-04	ERNST TIMOTHY S	EVP, General Counsel & Sec	Exercise / conversion M	Bio-Rad A Common Stock	1,250	$159.32	$199,150	2,362
2019-12-03	SCHWARTZ STEVEN D	10%	Equity grant / award G	Bio-Rad B Common Stock	40	$0.00	$0	12,811
2019-11-11	STARK JAMES R	VP, Corporate Controller	Open-market sell S	Bio-Rad A Common Stock	848	$351.45	$298,030	0
2019-09-12	TUMOLO ANNETTE	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	522	$330.00	$172,260	2,410
2019-09-11	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	600
2019-09-11	TUMOLO ANNETTE	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	238	$326.42	$77,688	2,932
2019-09-11	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	600	$0.00	$0	3,170
2019-09-11	HERTIA JOHN	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	600
2019-09-11	HERTIA JOHN	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	298	$326.42	$97,273	18,366
2019-09-11	HERTIA JOHN	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	600	$0.00	$0	18,664
2019-09-10	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	400	$0.00	$0	0
2019-09-10	TUMOLO ANNETTE	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	139	$322.93	$44,887	2,570
2019-09-10	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	400	$0.00	$0	2,709
2019-09-09	HERTIA JOHN	Executive Vice President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	600	$0.00	$0	1,200
2019-09-09	HERTIA JOHN	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	444	$336.47	$149,393	17,762
2019-09-09	HERTIA JOHN	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	600	$159.32	$95,592	18,206
2019-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Restricted Stock Units	400	$0.00	$0	800
2019-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	199	$335.59	$66,782	14,364
2019-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	400	$0.00	$0	14,563
2019-09-07	HUTTON RONALD W	Vice President and Treasurer	Exercise / conversion M · derivative	Restricted Stock Units	170	$0.00	$0	340
2019-09-07	HUTTON RONALD W	Vice President and Treasurer	Other disposed transaction F	Bio-Rad A Common Stock	59	$335.59	$19,800	4,371
2019-09-07	HUTTON RONALD W	Vice President and Treasurer	Exercise / conversion M	Bio-Rad A Common Stock	170	$0.00	$0	4,430
2019-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	3,000	$0.00	$0	6,000
2019-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	1,488	$339.71	$505,488	277,321
2019-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	3,000	$0.00	$0	278,809
2019-09-05	HUTTON RONALD W	Vice President and Treasurer	Exercise / conversion M · derivative	Restricted Stock Units	180	$0.00	$0	540
2019-09-05	HUTTON RONALD W	Vice President and Treasurer	Other disposed transaction F	Bio-Rad A Common Stock	63	$339.48	$21,387	4,260
2019-09-05	HUTTON RONALD W	Vice President and Treasurer	Exercise / conversion M	Bio-Rad A Common Stock	180	$0.00	$0	4,323
2019-09-04	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	2,400
2019-09-04	TUMOLO ANNETTE	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	208	$335.20	$69,722	1,896
2019-09-04	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	600	$0.00	$0	2,104
2019-09-04	HERTIA JOHN	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	2,400
2019-09-04	HERTIA JOHN	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	208	$335.20	$69,722	14,907
2019-09-04	HERTIA JOHN	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	600	$0.00	$0	15,115
2019-09-03	TUMOLO ANNETTE	Executive Vice President	Equity grant / award A · derivative	Non-Qualified Stock Option (right to buy)	2,784	$0.00	$0	2,784
2019-09-03	TUMOLO ANNETTE	Executive Vice President	Equity grant / award A · derivative	Restricted Stock Units	2,784	$0.00	$0	2,784
2019-08-14	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	310	$320.00	$99,200	103
2019-05-16	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	309	$299.31	$92,486	390
2019-05-16	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	192	$299.12	$57,351	699
2019-05-15	ERNST TIMOTHY S	EVP, General Counsel & Sec	Open-market sell S	Bio-Rad A Common Stock	345	$290.00	$100,050	891
2019-05-13	SCHWARTZ NORMAN D	Chairman, President and CEO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	37,000	$0.00	$0	0
2019-05-13	SCHWARTZ NORMAN D	Chairman, President and CEO	Other disposed transaction F	Bio-Rad B Common Stock	22,833	$296.28	$6,764,961	275,809
2019-05-13	SCHWARTZ NORMAN D	Chairman, President and CEO	Exercise / conversion M	Bio-Rad B Common Stock	37,000	$75.38	$2,789,060	298,642
2019-04-29	Last Andrew J.	EVP, Chief Operating Officer	Equity grant / award A · derivative	Non-Qualified Stock Option (right to buy)	5,000	$0.00	$0	5,000
2019-04-29	Last Andrew J.	EVP, Chief Operating Officer	Equity grant / award A · derivative	Restricted Stock Units	5,000	$0.00	$0	5,000
2019-04-08	Daskal Ilan	EVP, CFO	Equity grant / award A · derivative	Non-Qualified Stock Option (right to buy)	3,500	$0.00	$0	3,500
2019-04-08	Daskal Ilan	EVP, CFO	Equity grant / award A · derivative	Restricted Stock Units	3,500	$0.00	$0	3,500
2018-12-14	TSINGOS CHRISTINE A	EVP and CFO	Open-market sell S	Bio-Rad A Common Stock	1,411	$248.00	$349,928	6,683
2018-12-12	STARK JAMES R	VP, Corporate Controller	Open-market sell S	Bio-Rad A Common Stock	848	$254.77	$216,045	0
2018-12-11	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,200	$0.00	$0	1,800
2018-12-11	TUMOLO ANNETTE	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	1,200	$255.00	$306,000	1,504
2018-12-11	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	1,200	$159.32	$191,184	2,704
2018-12-11	TUMOLO ANNETTE	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	1,176	$254.00	$298,704	1,504
2018-12-10	SCHWARTZ STEVEN D	10%	Equity grant / award G	Bio-Rad B Common Stock	54	$0.00	$0	12,771
2018-09-11	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	1,200
2018-09-11	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	400	$0.00	$0	0
2018-09-11	TUMOLO ANNETTE	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	347	$308.37	$107,004	2,680
2018-09-11	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	1,000	$0.00	$0	3,027
2018-09-10	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	2,000	$0.00	$0	2,000
2018-09-10	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	992	$308.00	$305,536	258,665
2018-09-10	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	2,000	$0.00	$0	259,657
2018-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Restricted Stock Units	400	$0.00	$0	1,200
2018-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	199	$313.74	$62,434	11,346
2018-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	400	$0.00	$0	11,545
2018-09-07	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	1,800
2018-09-07	TUMOLO ANNETTE	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	208	$313.74	$65,258	1,766
2018-09-07	TUMOLO ANNETTE	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	600	$0.00	$0	1,974
2018-09-05	HERTIA JOHN	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	2,400
2018-09-05	HERTIA JOHN	Executive Vice President	Other disposed transaction F	Bio-Rad A Common Stock	208	$315.50	$65,624	12,954
2018-09-05	HERTIA JOHN	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	600	$0.00	$0	13,162
2018-09-04	TUMOLO ANNETTE	Executive Vice President	Equity grant / award A · derivative	Non-Qualified Stock Option (right to buy)	3,000	$0.00	$0	3,000
2018-09-04	TUMOLO ANNETTE	Executive Vice President	Equity grant / award A · derivative	Restricted Stock Units	3,000	$0.00	$0	3,000
2018-06-13	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	350	$303.42	$106,197	2,142
2018-05-11	SCHWARTZ NORMAN D	Chairman, President and CEO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	37,500	$0.00	$0	0
2018-05-11	SCHWARTZ NORMAN D	Chairman, President and CEO	Other disposed transaction F	Bio-Rad B Common Stock	24,273	$284.98	$6,917,320	256,145
2018-05-11	SCHWARTZ NORMAN D	Chairman, President and CEO	Exercise / conversion M	Bio-Rad B Common Stock	37,500	$88.48	$3,318,000	280,418
2017-12-14	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,000	$0.00	$0	1,500
2017-12-14	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	800	$0.00	$0	800
2017-12-14	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,280	$0.00	$0	640
2017-12-14	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,300	$0.00	$0	0
2017-12-14	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	600	$0.00	$0	0
2017-12-14	TSINGOS CHRISTINE A	EVP and CFO	Open-market sell S	Bio-Rad A Common Stock	4,980	$249.40	$1,242,020	6,683
2017-12-14	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M	Bio-Rad A Common Stock	1,000	$139.56	$139,560	11,663
2017-12-14	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M	Bio-Rad A Common Stock	800	$119.54	$95,632	10,663
2017-12-14	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M	Bio-Rad A Common Stock	1,280	$117.00	$149,760	9,863
2017-12-14	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M	Bio-Rad A Common Stock	1,300	$107.32	$139,516	8,583
2017-12-14	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M	Bio-Rad A Common Stock	600	$98.04	$58,824	7,283
2017-12-05	SCHWARTZ STEVEN D	10%	Equity grant / award G	Bio-Rad B Common Stock	53	$0.00	$0	12,717
2017-12-04	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	1,000	$258.39	$258,395	2,492
2017-11-30	STARK JAMES R	VP, Corporate Controller	Open-market sell S	Bio-Rad A Common Stock	746	$270.51	$201,798	0
2017-11-14	Magni Giovanni	EVP, Chief Strategy Officer	Open-market sell S	Bio-Rad A Common Stock	2,400	$253.01	$607,226	9,251
2017-09-13	Hall Shannon	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	1,245	$221.20	$275,390	565
2017-09-12	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Restricted Stock Units	240	$0.00	$0	0
2017-09-12	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	91	$218.04	$19,842	11,651
2017-09-12	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	240	$0.00	$0	11,742
2017-09-12	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M · derivative	Restricted Stock Units	200	$0.00	$0	0
2017-09-12	TSINGOS CHRISTINE A	EVP and CFO	Other disposed transaction F	Bio-Rad A Common Stock	76	$218.04	$16,571	6,683
2017-09-12	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M	Bio-Rad A Common Stock	200	$0.00	$0	6,759
2017-09-11	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M · derivative	Restricted Stock Units	500	$0.00	$0	1,500
2017-09-11	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M · derivative	Restricted Stock Units	160	$0.00	$0	160
2017-09-11	TSINGOS CHRISTINE A	EVP and CFO	Other disposed transaction F	Bio-Rad A Common Stock	249	$218.86	$54,496	6,559
2017-09-11	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M	Bio-Rad A Common Stock	660	$0.00	$0	6,808
2017-09-11	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Restricted Stock Units	500	$0.00	$0	1,500
2017-09-11	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Restricted Stock Units	240	$0.00	$0	240
2017-09-11	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	279	$218.86	$61,062	11,502
2017-09-11	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	740	$0.00	$0	11,781
2017-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Restricted Stock Units	400	$0.00	$0	800
2017-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	151	$218.42	$32,981	11,041
2017-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	400	$0.00	$0	11,192
2017-09-10	STARK JAMES R	VP, Corporate Controller	Exercise / conversion M · derivative	Restricted Stock Units	200	$0.00	$0	400
2017-09-10	STARK JAMES R	VP, Corporate Controller	Other disposed transaction F	Bio-Rad A Common Stock	76	$218.42	$16,600	311
2017-09-10	STARK JAMES R	VP, Corporate Controller	Exercise / conversion M	Bio-Rad A Common Stock	200	$0.00	$0	387
2017-09-10	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M · derivative	Restricted Stock Units	400	$0.00	$0	800
2017-09-10	TSINGOS CHRISTINE A	EVP and CFO	Other disposed transaction F	Bio-Rad A Common Stock	151	$218.42	$32,981	6,148
2017-09-10	TSINGOS CHRISTINE A	EVP and CFO	Exercise / conversion M	Bio-Rad A Common Stock	400	$0.00	$0	6,299
2017-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Restricted Stock Units	400	$0.00	$0	1,600
2017-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Other disposed transaction F	Bio-Rad A Common Stock	151	$218.42	$32,981	10,792
2017-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	400	$0.00	$0	10,943
2017-09-07	STARK JAMES R	VP, Corporate Controller	Exercise / conversion M · derivative	Restricted Stock Units	300	$0.00	$0	1,200
2017-09-07	STARK JAMES R	VP, Corporate Controller	Other disposed transaction F	Bio-Rad A Common Stock	113	$215.44	$24,345	187
2017-09-07	STARK JAMES R	VP, Corporate Controller	Exercise / conversion M	Bio-Rad A Common Stock	300	$0.00	$0	300
2017-09-05	TSINGOS CHRISTINE A	EVP and CFO	Equity grant / award A · derivative	Non-Qualified Stock Option (right to buy)	3,000	$0.00	$0	3,000
2017-09-05	TSINGOS CHRISTINE A	EVP and CFO	Equity grant / award A · derivative	Restricted Stock Units	3,000	$0.00	$0	3,000
2017-08-11	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	700	$215.91	$151,136	2,060
2017-08-10	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,600	$0.00	$0	6,400
2017-08-10	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	2,400	$0.00	$0	3,600
2017-08-10	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	1,920	$0.00	$0	1,280
2017-08-10	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	2,600	$0.00	$0	650
2017-08-10	GOETZ JOHN	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	1,332	$215.00	$286,380	63,028
2017-08-10	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	1,600	$139.56	$223,296	64,360
2017-08-10	GOETZ JOHN	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	1,891	$215.00	$406,565	62,760
2017-08-10	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	2,400	$119.54	$286,896	64,651
2017-08-10	GOETZ JOHN	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	1,502	$215.00	$322,930	62,251
2017-08-10	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	1,920	$117.00	$224,640	63,753
2017-08-10	GOETZ JOHN	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	1,978	$215.00	$425,270	61,833
2017-08-10	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	2,600	$107.32	$279,032	63,811
2017-06-01	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other acquired transaction J	Bio-Rad B Common Stock	20,588	$0.00	$0	236,451
2017-05-31	Hall Shannon	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	900	$222.65	$200,387	560
2017-05-26	HINCKLEY GREGORY K	Dir	Open-market buy P	Bio-Rad A Common Stock	500	$219.58	$109,792	500
2017-05-23	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	37,500	$0.00	$0	0
2017-05-23	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	25,605	$216.00	$5,530,680	215,863
2017-05-23	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	37,500	$75.00	$2,812,500	241,468
2017-05-18	Magni Giovanni	EVP, Chief Strategy Officer	Open-market sell S	Bio-Rad A Common Stock	2,113	$220.23	$465,346	10,543
2017-05-11	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,500	$0.00	$0	0
2017-05-11	GOETZ JOHN	EVP, Chief Operating Officer	Open-market sell S	Bio-Rad A Common Stock	3,500	$220.17	$770,590	61,174
2017-05-11	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	3,500	$88.00	$308,000	64,674
2017-05-10	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,500	$0.00	$0	0
2017-05-10	GOETZ JOHN	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	2,563	$223.00	$571,549	61,174
2017-05-10	GOETZ JOHN	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	2,462	$223.00	$549,026	60,237
2017-05-10	GOETZ JOHN	EVP, Chief Operating Officer	Other disposed transaction F	Bio-Rad A Common Stock	2,271	$223.00	$506,433	59,199
2017-05-10	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	3,500	$98.04	$343,140	63,737
2017-03-07	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	300	$196.13	$58,840	2,760
2017-03-06	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,500	$0.00	$0	0
2017-03-06	Magni Giovanni	EVP, Chief Strategy Officer	Open-market sell S	Bio-Rad A Common Stock	3,500	$195.87	$685,528	12,656
2017-03-06	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	3,500	$75.32	$263,620	16,156
2017-03-06	Magni Giovanni	EVP, Chief Strategy Officer	Open-market sell S	Bio-Rad A Common Stock	998	$196.16	$195,771	12,656
2017-03-02	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M · derivative	Non-Qualified Stock Option (right to buy)	3,500	$0.00	$0	0
2017-03-02	GOETZ JOHN	EVP, Chief Operating Officer	Open-market sell S	Bio-Rad A Common Stock	3,500	$196.34	$687,189	57,922
2017-03-02	GOETZ JOHN	EVP, Chief Operating Officer	Exercise / conversion M	Bio-Rad A Common Stock	3,500	$75.32	$263,620	61,422
2016-12-09	SCHWARTZ STEVEN D	10%	Equity grant / award G	Bio-Rad B Common Stock	78	$0.00	$0	12,664
2016-11-09	STARK JAMES R	VP, Corporate Controller	Open-market sell S	Bio-Rad A Common Stock	1,299	$171.42	$222,675	0
2016-11-07	Hall Shannon	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	84	$165.62	$13,912	1,390
2016-11-04	Hall Shannon	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	220	$0.00	$0	0
2016-11-04	Hall Shannon	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	220	$0.00	$0	1,474
2016-09-12	HERTIA JOHN	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	728	$155.02	$112,856	9,885
2016-09-12	Magni Giovanni	EVP, Chief Strategy Officer	Open-market sell S	Bio-Rad A Common Stock	438	$155.02	$67,898	13,357
2016-09-12	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	2,617	$0.00	$0	2,617
2016-09-12	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	1,366	$159.32	$217,631	202,743
2016-09-12	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	2,617	$0.00	$0	204,109
2016-09-12	SCHWARTZ ALICE N	Dir	Equity grant / award G	Bio-Rad A Common Stock	6,370	$0.00	$0	1,800,281
2016-09-11	HERTIA JOHN	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	2,400
2016-09-11	HERTIA JOHN	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	700	$0.00	$0	1,400
2016-09-11	HERTIA JOHN	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	1,300	$0.00	$0	10,613
2016-09-11	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Restricted Stock Units	500	$0.00	$0	2,000
2016-09-11	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Restricted Stock Units	240	$0.00	$0	480
2016-09-11	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	740	$0.00	$0	13,795
2016-09-11	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	3,200	$0.00	$0	12,800
2016-09-11	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	2,600	$0.00	$0	5,200
2016-09-11	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	3,027	$159.80	$483,715	201,492
2016-09-11	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	5,800	$0.00	$0	204,519
2016-09-10	HERTIA JOHN	Executive Vice President	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	1,800
2016-09-10	HERTIA JOHN	Executive Vice President	Exercise / conversion M	Bio-Rad A Common Stock	600	$0.00	$0	9,313
2016-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M · derivative	Restricted Stock Units	400	$0.00	$0	1,200
2016-09-10	Magni Giovanni	EVP, Chief Strategy Officer	Exercise / conversion M	Bio-Rad A Common Stock	400	$0.00	$0	13,055
2016-09-10	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M · derivative	Restricted Stock Units	2,000	$0.00	$0	6,000
2016-09-10	SCHWARTZ NORMAN D	Chairman, President, and CEO	Other disposed transaction F	Bio-Rad B Common Stock	1,044	$159.80	$166,831	198,719
2016-09-10	SCHWARTZ NORMAN D	Chairman, President, and CEO	Exercise / conversion M	Bio-Rad B Common Stock	2,000	$0.00	$0	199,763
2016-09-09	HERTIA JOHN	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	2,689	$158.57	$426,395	8,713
2016-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Equity grant / award A · derivative	Non-Qualified Stock Option (right to buy)	2,000	$0.00	$0	2,000
2016-09-08	Magni Giovanni	EVP, Chief Strategy Officer	Equity grant / award A · derivative	Restricted Stock Units	2,000	$0.00	$0	2,000
2016-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Equity grant / award A · derivative	Non-Qualified Stock Option (right to buy)	15,000	$0.00	$0	15,000
2016-09-07	SCHWARTZ NORMAN D	Chairman, President, and CEO	Equity grant / award A · derivative	Restricted Stock Units	15,000	$0.00	$0	15,000
2016-08-18	Crowley Michael	EVP, GBL Commercial Operations	Open-market sell S	Bio-Rad A Common Stock	669	$153.00	$102,357	1,868
2016-06-13	Hall Shannon	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	281	$145.31	$40,891	336
2016-06-13	Hall Shannon	Executive Vice President	Open-market sell S	Bio-Rad A Common Stock	1,291	$145.29	$187,569	617
2016-06-10	SCHWARTZ ALICE N	Dir	Open-market sell S	Bio-Rad A Common Stock	7,000	$147.02	$1,029,140	1,806,651

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count